Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Fortress Biotech (FBIO) FCF Payout Ratio (2017 - 2025)

Historic FCF Payout Ratio for Fortress Biotech (FBIO) over the last 9 years, with Q3 2025 value amounting to 0.03.

  • Fortress Biotech's FCF Payout Ratio changed N/A to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01, marking a year-over-year increase of 8722.0%. This contributed to the annual value of 0.05 for FY2024, which is 2001.1% up from last year.
  • Latest data reveals that Fortress Biotech reported FCF Payout Ratio of 0.03 as of Q3 2025.
  • Fortress Biotech's 5-year FCF Payout Ratio high stood at 0.0 for Q3 2022, and its period low was 0.09 during Q1 2021.
  • For the 5-year period, Fortress Biotech's FCF Payout Ratio averaged around 0.03, with its median value being 0.03 (2025).
  • Its FCF Payout Ratio has fluctuated over the past 5 years, first skyrocketed by 9386.0% in 2021, then tumbled by 145604.52% in 2024.
  • Over the past 5 years, Fortress Biotech's FCF Payout Ratio (Quarter) stood at 0.05 in 2021, then rose by 15.23% to 0.04 in 2022, then crashed by 37.17% to 0.06 in 2023, then crashed by 50.49% to 0.09 in 2024, then skyrocketed by 68.57% to 0.03 in 2025.
  • Its FCF Payout Ratio stands at 0.03 for Q3 2025, versus 0.01 for Q2 2025 and 0.01 for Q1 2025.